SUMMARY A double staining immunofluorescence method was developed that allowed the reliable differential counting of cells containing cytoplasmic immunoglobulin in human bone marrow. These cells were stained with a polyspecific antihuman immunoglobulin serum conjugated with rhodamine. In separate preparations subpopulations of cells containing each heavy chain class and light chain type were identified by prior staining with isotype specific fluorescein conjugated antihuman immunoglobulin sera. A standardised counting procedure was adopted to indicate the degree of plasma cell infiltration and to establish the percentage of cells containing each type of immunoglobulin.
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A series of 122 patients requiring haematological investigation of the bone marrow for various disorders but without evidence of paraproteinaemia was tested to provide results for a nonmyelomatous reference group. These results were compared with those from 40 patients with paraproteins of various classes in their serum. The procedure described here clearly differentiated the two groups. When combined with serum paraprotein assays and conventional haematological cytology of bone marrow these counts provided useful additional information in cases of diagnostic difficulty and in the assessment of individual patients before, during, and after treatment.
The laboratory diagnosis of myelomatosis relies on the finding of paraprotein in serum or of free immunoglobulin (Ig) light chains in urine, together with the presence of atypical or particularly numerous plasma cells in the bone marrow. Paraproteinaemia can occur in the absence of overt myeloma and without obvious cytological abnormalities in conventional haematological preparations of bone marrow.
Serial measurements of the concentration of paraproteins in the serum and conventional cytological examination of bone marrow are also used to monitor the progress of the disease, but, although they are generally useful, clinical experience shows Accepted for publication 16 May 1985 them to be misleading in a considerable number of cases.
Immunofluorescence has been used to show the presence of cytoplasmic immunoglobulin (Ig) in plasma cells, ' and Nucleated cells were freed from fragments by vortex mixing, thoroughly washed free of plasma and red blood cells, and deposited on slides using a cytocentrifuge (Shandon, Runcorn). Samples were centrifuged at 800 g for five minutes. Floating fragments were taken into 2 ml washing fluid in the 15 ml conical centrifuge tube and mixed vigorously in a vortex for 30 seconds.
After standing for two minutes any remaining floating fragments were transferred to a second centrifuge tube containing 2 ml washing fluid and vortex mixed for a further 30 seconds to free cells from fragments. The rest of the marrow was taken into a Wintrobe's/haematocrit tube and spun at 800 g for five minutes, and the buffy coat was pooled with the suspensions of cells freed from the fragments. These cells were suspended in 30 ml washing fluid in two tubes and gently centrifuged at 125 g for 15 minutes. The supematant was discarded and the deposit resuspended in washing fluid at a concentration of 1 x 109 nucleated cells. The cytocentrifuge was loaded with cleaned, labelled slides, and 200 ,uVI washed marrow suspension was added to each cup (2 x 105 nucleated cells) and centrifuged at 75 g for eight minutes.
The cytocentrifuge procedure was repeated on the other end of the slide to give two spot preparations on each slide. Preparations were dried in air in front of a fan for 15 minutes, and each spot was scored around the edge with a diamond pencil to aid later visualisation. Slides were stored in plastic slide boxes with silica gel inside sealed plastic bags at -70°C for up to two years: they were fixed immediately before staining. The mean value for the incidence of cells containing cytoplasmic immunogiobulin in patients without serum paraprotein by this method was 6% (SEM 0.6). Table 1 presents the results for the differential counts, together with the ratio of cells containing K and X light chains. A reference range derived from these results facilitated comparison when the results in each patient were assessed (Table 1) . Table 2 shows the results obtained from testing the bone marrow of patients with readily detectable paraprotein in their serum together with the immunochemical class of their paraprotein.
Discussion
Immunochemical assays of serum and urine, together with haematological assessment of bone marrow, are widely used in the investigation of myeloma and monoclonal gammopathies of undetermined significance. The presence of cytoplasmic Ig in bone marrow cells shown by immunofluorescence has been used to elucidate cases in which diagnosis has been difficult.3
In the original method separate preparations were stained with monospecific fluorescein conjugated antisera to each Ig heavy chain and light chain type.2 The cells staining in each heavy chain stained preparation were counted and expressed as a percentage of the total counted in all the heavy chain preparations. Similar procedures were carried out for the light chain counts. Thus the sums of the heavy chain counts and of the light chain counts were always 100%. Alternatively, the stained cells could be counted in a defined number of optical microscope fields or the counts for each preparation could be expressed as a total of the nucleated cells seen.
These counts showed monoclonal proliferations in most cases in which they existed, but inaccuracies resulting from the differences in the distribution of cells between one preparation and another limited their value in showing fine variations of pathological importance and in the assessment of progression of disease or response to treatment.
The procedure described here overcame these In the diagnosis of myelomatosis and the assessment of paraproteinaemia adequate, readily available tests are required that will indicate the extent of the tumour burden and the stage and rate of progression of disease and that will measure responses to treatment. The double staining immunofluorescence investigation of bone marrow aspirates described here offered an additional source of information that was useful in the assessment of patients with myeloma and associated disorders.
The usefulness of this procedure in cases of diagnostic difficulty and in the management of individual cases will be reported separately.
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